Don Sharpe talks to Stuart Genschaw, Exec. Dir. of Cancer & Hematology Centers of Western Michigan about innovation within oncology…
Don Sharpe asks the question Why are you embracing payment reform at The Center for Cancer and Blood Disorders to…
Don Sharpe discusses the success at Advanced Medical Specialties using Accountable Care Organization (ACO) with Dr. Leonard Kalman, MD from…
Don Sharpe talks to Dr. Barbara McAneny, MD from New Mexico Cancer Center about the CMMI Award and setting up…
Don Sharpe talks about the importance of cancer patient advocacy from the point of view of a medical oncologists Dr.…
Don Sharpe discusses Dr Erin Dunbar, MD or Piedmont Healthcare her presentation entitled “Good News from the Oncologist” at the…
Don Sharpe of OBR talks to Dr. Lucio Gordon, MD of Florida Cancer Specialists about the role of IT, Electronic…
Don Sharpe talks to Angel Aslo, PharmD about the role of in house pharmacies within the community oncology setting.
Don Sharpe discusses with Ray Bailey, PharmD the role in which in house pharmacies play within oncology practices.
Don Sharpe of OBR discusses a surprise announcement from Dr. Siddhartha Mukherjee author and Pulitzer prize winner for The Emperor…
Don Sharpe of OBR discusses molecular profiling with Dr. John Powderly of Carolina BioOncology Institute at COA.
Don Sharpe discusses with Ray Bailey, PharmD the role in which in house pharmacies play within oncology practices.
Don Sharpe of OBR discusses a surprise announcement from Dr. Siddhartha Mukherjee author and Pulitzer prize winner for The Emperor…
Don Sharpe of OBR discusses molecular profiling with Dr. John Powderly of Carolina BioOncology Institute at COA.
Stato dell’arte e ricerca clinica attuale (PRIMA PARTE) 7 ° Riunione Nazionale AIG Associazione Italiana GIST Onlus Bologna 29 marzo…
7° Riunione Nazionale A.I.G. Associazione Italiana GIST Onlus Bologna 29 marzo 2014
Terapia Sunitinib: verso la personalizzazione della cura. 7° Riunione Annuale A.I.G. Associazione Italiana GIST Onlus, Bologna 29 marzo 2014
Dott. Paolo G. Casali, Responsabile SSD Oncologia Medica Tumori Mesenchimali dell’Adulto, Fondazione IRCCS Istituto Nazionale Tumori – Milano 7° Riunione…
Messaggio dell’Associazione e Introduzione ai lavori 7° Riunione Nazionale A.I.G. Associazione Italiana GIST Onlus Bologna 29 marzo 2014
Imatininb nella terapia pre-operatoria, adiuvante e di prima linea nel trattamento del GIST 7° Riunione Nazionale A.I.G. Associazione Italiana GIST…
Benvenuto e introduzione 7° Riunione Nazionale di A.I.G. Associazione Italiana GIST Onlus Bologna, 29 marzo 2014
SAN FRANCISCOThe ability of cancer cells to evolve clonally into molecularly distinct strands needs to be considered when selecting targeted…
NEW ORLEANSHigh remission rates with extended survival are being achieved in patients who had failed all other therapies including allogeneic…
LONDON Researchers have shown that endometrial cancer and hopefully ovarian cancer too could potentially be detected much earlier than at…
ORLANDO, FLORIDAPatients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from…
SAN FRANCISCONew research has shown the alpha-emitting drug radium 233 to be a benign therapy with no major toxicities while…
SAN FRANCISCO The orally administered androgen receptor blocker enzalutamide significantly extended both overall survival and radiographically determined progression-free survival in…
NEW ORLEANSA new oral tyrosine kinase inhibitor drug idelalisib has proved effective and to have low toxicity in patients with…
The rare, fatal lympho-proliferative condition: Multicentric Castleman’s Disease MCD could soon be treatable following findings announced at the American Society…
WASHINGTON DCA new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no…
CAMBRIDGE, UKA new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui…
ORLANDO, FLORIDAA decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients…
ORLANDO, FLORIDAPatients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr…
3-9-14 9:01am
3-9-14 8:50am
3-7-14 10:54 FLV
3-7-14 3:10pm
In this presentation from “Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies”, Dr. Angela Dispenzieri discusses who should…